577 Robat, C.S., L. Cesario, R. Gaeta, et al. 2013b. Clinical features, treatment options, and outcome in dogs with thymoma: 116 cases (1999–2010). J Am Vet Med Assoc 243:1448–1454.
578 Robat, C., C. London, L. Bunting, et al. 2012. Safety evaluation of combination vinblastine and toceranib phosphate (Palladia(R)) in dogs: A phase I dose‐finding study. Vet Comp Oncol 10:174–183.
579 Robben, J.H., W.E. Van Den Brom, J.A. Mol, et al. 2006. Effect of octreotide on plasma concentrations of glucose, insulin, glucagon, growth hormone, and cortisol in healthy dogs and dogs with insulinoma. Res Vet Sci 80:25–32.
580 Rodenas, S., I. Valin, P. Devauchelle, et al. 2006. Combined use of surgery and radiation in the treatment of an intradural myxoid liposarcoma in a dog. J Am Anim Hosp Assoc 42:386–391.
581 Romansik, E.M., C.M. Reilly, P.H. Kass, et al. 2007. Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 44:335–341.
582 Rosales, C., K.A. Jeglum, M. Obrocka, et al. 1988. Cytolytic activity of murine anti‐dog lymphoma monoclonal antibodies with canine effector cells and complement. Cell Immunol 115:420–428.
583 Ross, J.T., T.D. Scavelli, D.T. Matthieson, et al. 1991. Adenocarcinoma of the apocrine glands of the anal sac in dogs: A review of 32 cases. J Am Anim Hosp Assoc 27:349–355.
584 Rottenberg, S., C. Von Tscharner, and P.J. Roosje. 2004. Thymoma‐associated exfoliative dermatitis in cats. Vet Pathol 41:429–433.
585 Rovesti, G.L., M. Bascucci, K. Schmidt, et al. 2002. Limb sparing using a double bone‐transport technique for treatment of a distal tibial osteosarcoma in a dog. Vet Surg 31:70–77.
586 Rusbridge, C., S.J. Wheeler, C.R. Lamb, et al. 1999. Vertebral plasma cell tumors in 8 dogs. J Vet Intern Med 13:126–133.
587 Saam, D.E., J.M. Liptak, M.J. Stalker, et al. 2011. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996–2006). J Am Vet Med Assoc 238:195–206.
588 Saba, C.F., S.D. Hafeman, D.M. Vail, et al. 2009. Combination chemotherapy with continuous L‐asparaginase, lomustine, and prednisone for relapsed canine lymphoma. J Vet Intern Med 23:1058–1063.
589 Saba, C.F., D.H. Thamm, and D.M. Vail. 2007. Combination chemotherapy with L‐asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma. J Vet Intern Med 21:127–132.
590 Saba, C.F., D.M. Vail, and D.H. Thamm. 2012. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine‐associated sarcoma. Vet Comp Oncol 10:283–291.
591 Saeki, K., A. Fujita, N. Fujita, et al. 2015. Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: A report of 10 cases (2005–2011). Can Vet J 56:73–80.
592 Salinardi, B.J., S.L. Marks, J.R. Davidson, et al. 2003. The use of a low‐profile cystostomy tube to relieve urethral obstruction in a dog. J Am Anim Hosp Assoc 39:403–405.
593 Salm, R., B. Wullich, G. Kiefer, et al. 1991. Effects of a three‐drug antineoplastic protocol of wound healing in rats: A biomechanical and histologic study on gastrointestinal anastomoses and laparotomy wounds. J Surg Oncol 47:5–11.
594 Santos, A.A., C.C. Lopes, J.R. Ribeiro, et al. 2013. Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study. BMC Vet Res 9:1.
595 Sartor, L.L., L.A. Trepanier, M.M. Kroll, et al. 2004. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. J Vet Intern Med 18:651–655.
596 Sauerbrey, M.L., M.N. Mullins, E.O. Bannink, et al. 2007. Lomustine and prednisone as a first‐line treatment for dogs with multicentric lymphoma: 17 cases (2004–2005). J Am Vet Med Assoc 230:1866–1869.
597 Saulnier‐Troff, F.G., V. Busoni, and A. Hamaide. 2008. A technique for resection of invasive tumors involving the trigone area of the bladder in dogs: Preliminary results in two dogs. Vet Surg 37:427–437.
598 Scase, T.J., D. Edwards, J. Miller, et al. 2006. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 20:151–158.
599 Schrempp, D.R., M.O. Childress, J.C. Stewart, et al. 2013. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma. J Am Vet Med Assoc 242:1534–1538.
600 Schuller, D.E., B. Metch, D.W. Stein, et al. 1988. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98:1205–1211.
601 Schultheiss, P.C. 2004. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 16:522–526.
602 Schwarz, P.D., S.J. Withrow, C.R. Curtis, et al. 1991b. Mandibular resection as a treatment for oral cancer in 81 dogs. J Am Anim Hosp Assoc 27:601–610.
603 Schwarz, P.D., S.J. Withrow, C.R. Curtis, et al. 1991a. Partial maxillary resection as a treatment for oral cancer in 61 dogs. J Am Anim Hosp Assoc 27:617–624.
604 Scott‐Moncrieff, J.C., H.G. Heng, H.Y. Weng, et al. 2015. Effect of a limited iodine diet on iodine uptake by thyroid glands in hyperthyroid cats. J Vet Intern Med 29:1322–1326.
605 Seguin, B., N.F. Leibman, V.S. Bregazzi, et al. 2001. Clinical outcome of dogs with grade‐II mast cell tumors treated with surgery alone: 55 cases (1996–1999). J Am Vet Med Assoc 218:1120–1123.
606 Seguin, B., D.E. McDonald, M.S. Kent, et al. 2005. Tolerance of cutaneous or mucosal flaps placed into a radiation therapy field in dogs. Vet Surg 34:214–222.
607 Seguin, B., M.D. O’Donnell, P.J. Walsh, et al. 2017. Long‐term outcome of dogs treated with ulnar rollover transposition for limb‐sparing of distal radial osteosarcoma: 27 limbs in 26 dogs. Vet Surg 46:1017–1024.
608 Seguin, B., P.J. Walsh, D.R. Mason, et al. 2003. Use of an ipsilateral vascularized ulnar transposition autograft for limb‐sparing surgery of the distal radius in dogs: An anatomic and clinical study. Vet Surg 32:69–79.
609 Seiler, R.J. 1979. Colorectal polyps of the dog: A clinicopathologic study of 17 cases. J Am Vet Med Assoc 174:72–75.
610 Selmic, L.E., J.H. Burton, D.H. Thamm, et al. 2014. Comparison of carboplatin and doxorubicin‐based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med 28:554–563.
611 Selting, K.A., B.E. Powers, L.J. Thompson, et al. 2005. Outcome of dogs with high‐grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996–2004). J Am Vet Med Assoc 227:1442–1448.
612 Seo, K.W., U.S. Choi, Y.C. Jung, et al. 2007. Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog. J Vet Med Sci 69:201–204.
613 Shirafuji, T., T. Oka, T. Sawada, et al. 2001. The importance of peripheral blood leukocytes and macrophage infiltration on bronchial wall wound healing in rats treated preoperatively with anticancer agents. Surg Today 31:308–316.
614 Shiu, K.B., A.B. Flory, C.L. Anderson, et al. 2011. Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma. J Am Vet Med Assoc 238:472–479.
615 Sicotte, V., J. Benamou, L.C. Fifle, et al. 2012. Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma. J Am Vet Med Assoc 241:1639–1644.
616 Silver, M., A. Rusk, B. Phillips, et al. 2012. Evaluation of the oral antimitotic agent (Abt‐751) in dogs with lymphoma. J Vet Intern Med 26:349–354.
617 Simcock, J.O., S.S. Withers, C.Y. Prpich, et al. 2012. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006–2010). J Am Vet Med Assoc 241:608–614.
618 Simpson,